Home/Filings/4/0001593034-20-000014
4//SEC Filing

Coleman Blaise 4

Accession 0001593034-20-000014

CIK 0001593034other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:44 PM ET

Size

17.5 KB

Accession

0001593034-20-000014

Insider Transaction Report

Form 4
Period: 2020-02-21
Coleman Blaise
SVP Glob Finance & Interim CFO
Transactions
  • Tax Payment

    Ordinary Shares

    2020-02-21$6.19/sh3,121$19,319118,059 total
  • Tax Payment

    Ordinary Shares

    2020-02-23$6.19/sh105$650118,329 total
  • Exercise/Conversion

    Stock Incentive Plan Performance Share Units

    2020-02-2533,169144,226 total
  • Exercise/Conversion

    Ordinary Shares

    2020-02-25+30,395148,724 total
  • Tax Payment

    Ordinary Shares

    2020-02-25$6.19/sh8,579$53,104140,145 total
Footnotes (10)
  • [F1]Thirty-three and one-third percent (33 1/3%) of Mr. Coleman's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2020.
  • [F10]These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of performance share units.
  • [F2]These shares represent stock withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting of RSUs.
  • [F3]Represents the vesting price which is the average of the high and low share price on February 21, 2020.
  • [F4]Twenty-five percent (25%) of Mr. Coleman's February 23, 2016 grant of RSUs vested on February 23, 2020.
  • [F5]Represents the vesting price which is the average of the high and low share price on February 21, 2020, the last trading day prior to vesting.
  • [F6]On February 25, 2020, based on performance against target levels with respect to Mr. Coleman's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 30,395 ordinary shares. Of this amount, 8,579 ordinary shares were withheld by Endo International plc to satisfy Mr. Coleman's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Coleman.
  • [F7]Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods.
  • [F8]These securities were granted to Mr. Coleman in consideration of his services as the Executive Vice President and Chief Financial Officer of Endo International plc.
  • [F9]This represents the automatic conversion of performance share units granted to Mr. Coleman on February 21, 2017 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement.

Issuer

Endo International plc

CIK 0001593034

Entity typeother

Related Parties

1
  • filerCIK 0001689280

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:44 PM ET
Size
17.5 KB